Aligos Therapeutics Inc (ALGS): Next-Year EPS Estimate 36.27%
As of 2026-06-11, Aligos Therapeutics Inc (ALGS) has a next-year EPS growth estimate of 36.27%.
On 2026-05-31, analyst consensus for ALGS's next-year EPS growth shifted from 38.78% to 36.27% — a negative change of 2.51 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at -187.75%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 36.27%
- EPS growth this year
- -187.75%
- EPS next quarter (est)
- -$1.00
- Last price
- $5.28
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 36.27% | -187.75% | -$1.00 | $5.28 |
| 2026-06-10 | 36.27% | -187.75% | -$1.00 | $5.16 |
| 2026-06-09 | 36.27% | -187.75% | -$1.00 | $5.14 |
| 2026-06-08 | 36.27% | -187.75% | -$1.00 | $4.96 |
| 2026-06-07 | 36.27% | -187.75% | -$1.00 | $4.91 |
| 2026-06-04 | 36.27% | -187.75% | -$1.00 | $5.34 |
| 2026-06-03 | 36.27% | -187.75% | -$1.00 | $5.14 |
| 2026-06-02 | 36.27% | -187.75% | -$1.00 | $5.25 |
| 2026-06-01 | 36.27% | -187.75% | -$1.00 | $5.35 |
| 2026-05-31 | 36.27% | -187.75% | -$1.00 | $5.70 |
| 2026-05-28 | 38.78% | -213.29% | -$1.15 | $5.79 |
| 2026-05-27 | 38.78% | -213.29% | -$1.15 | $5.60 |
| 2026-05-26 | 38.78% | -213.29% | -$1.15 | $5.74 |
| 2026-05-25 | 38.78% | -213.29% | -$1.15 | $5.76 |
| 2026-05-24 | 38.78% | -213.29% | -$1.15 | $5.76 |
| 2026-05-21 | 38.78% | -213.29% | -$1.15 | $5.71 |
| 2026-05-20 | 40.08% | -215.64% | -$1.29 | $5.60 |
| 2026-05-19 | 40.08% | -215.64% | -$1.29 | $5.18 |
| 2026-05-18 | 40.08% | -215.64% | -$1.29 | $5.36 |
| 2026-05-17 | 40.08% | -215.64% | -$1.29 | $5.71 |
| 2026-05-14 | 40.08% | -215.64% | -$1.29 | $6.69 |
| 2026-05-13 | 40.08% | -215.64% | -$1.29 | $6.66 |
| 2026-05-12 | 40.08% | -215.64% | -$1.29 | $6.47 |
| 2026-05-11 | 38.90% | -207.55% | -$1.19 | $6.21 |
| 2026-05-10 | 46.21% | -220.13% | -$1.77 | $6.44 |
| 2026-05-07 | 28.63% | -176.74% | -$2.21 | $6.03 |
| 2026-05-06 | 28.63% | -176.74% | -$2.21 | $6.37 |
| 2026-05-05 | 28.63% | -176.74% | -$2.21 | $6.35 |
| 2026-05-04 | 28.63% | -176.74% | -$2.21 | $6.44 |
| 2026-05-03 | 28.63% | -176.74% | -$2.21 | $6.09 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Aligos Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Aligos Therapeutics Inc (ALGS) has a next-year EPS growth estimate of 36.27%, based on analyst consensus.
When was the latest EPS estimate revision for ALGS?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 38.78% to 36.27%.
What sector and industry does Aligos Therapeutics Inc belong to?▾
Aligos Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALGS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Aligos Therapeutics Inc (ALGS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports